RELMADA THERAPEUTICS, INC. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4/A — Form 4/A

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2019-12-24

Reporting Person: CASAMENTO CHARLES J (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	62534	Direct

Footnotes

F1: The original Form 4, filed on December 27, 2019 (the "Original Form 4"), inadvertently reported 61,484 as the amount of shares of common stock directly owned by the Reporting Person following the transactions reported therein. In fact, as reported in this amendment, the Reporting Person directly owned 62,534 shares of common stock following the transactions reported in the Original Form 4. The Original Form 4 is being amended by this amendment solely to correct such amount. The Reporting Person's beneficial ownership of the additional 1,050 shares (after giving effect to an intervening 1-for-4 reverse stock split) was previously reported by him in a Form 4 filed on December 16, 2015.